NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is inviting applications for the NINDS Exploratory Clinical Trials for Small Business (R43/R44) grant, aimed at supporting small business concerns (SBCs) in conducting exploratory clinical trials related to neurological disorders. This funding opportunity focuses on projects that evaluate drugs, biologics, devices, and various therapeutic strategies, with an emphasis on advancing diagnostics and therapies aligned with the mission of the National Institute of Neurological Disorders and Stroke (NINDS). Eligible applicants must demonstrate plans for future clinical development and include a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research. The funding caps are set at $295,924 for Phase I and $1,972,828 for Phase II, with an application deadline of January 5, 2024. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
Eligible Applicants
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.